From: Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort study
Urine culture result | Number (% of all patients)a | Number with ESBL (% of cases with this organism)b | Number nitrofurantoin sensitive (% of cases with this organism)b | Number fosfomycin sensitive (% of cases with this organism)b |
---|---|---|---|---|
Escherichia coli | 52/75 (69.3) | 31/52 (58.5) | 30/52 (56.6) | 49/50 (98.0) |
Klebsiella pneumoniae | 9/75 (12.0) | 6/9 (66.7) | 1/9 (11.1) | 9/9 (100.0) |
Other Enterobacteriaceae in pure growth | 6/75 (8.0) | 0/6 (0) | 0/6 (0) | 5/6 (83.3) |
Pseudomonas | 1/75 (1.3) | n/a | n/a | n/d |
Mixed growth | 4/75 (5.3) | n/a | n/a | n/a |
No significant growth | 2/75 (2.7) | n/a | n/a | n/a |
No data | 1/75 (1.3) | n/a | n/a | n/a |
Total | 75/75 | 37/61 | 31/61 | 63/65 |